Found: 3
Select item for more details and to access through your institution.
SYTL5 Promotes Papillary Thyroid Carcinoma Progression by Enhancing Activation of the NF-κB Signaling Pathway.
- Published in:
- Endocrinology, 2024, v. 165, n. 9, p. 1, doi. 10.1210/endocr/bqac187
- By:
- Publication type:
- Article
SYTL5 Promotes Papillary Thyroid Carcinoma Progression by Enhancing Activation of the NF-κB Signaling Pathway.
- Published in:
- Endocrinology, 2024, v. 165, n. 1, p. 1, doi. 10.1210/endocr/bqac187
- By:
- Publication type:
- Article
SYTL5 Promotes Papillary Thyroid Carcinoma Progression by Enhancing Activation of the NF-κB Signaling Pathway.
- Published in:
- Endocrinology, 2023, v. 164, n. 1, p. 1, doi. 10.1210/endocr/bqac187
- By:
- Publication type:
- Article